Cargando…
Impact of local treatment on survival from hematological malignancies causing spinal cord compression
BACKGROUND: Various hematological malignancies, including multiple myeloma, plasmacytoma, aggressive lymphoma, and indolent lymphoma, rarely result in spinal cord compression. METHODS: Here, we retrospectively analyzed 32 patients with multiple myeloma (50%), plasmacytoma (13%), aggressive lymphoma...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific Scholar
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656002/ https://www.ncbi.nlm.nih.gov/pubmed/33194285 http://dx.doi.org/10.25259/SNI_592_2020 |
_version_ | 1783608286604427264 |
---|---|
author | Ghedira, Hela Radhouane, Khaled Mezni, Essia Yahiaoui, Safia Stambouli, Hela Yedeas, Mohamed Dehmani Belaid, Asma Ammar, Chiraz Kacem, Karima Zriba, Samy Msadek, Fehmi Yedeas, Mondher Harbaoui, Ahmed Chkili, Ridha |
author_facet | Ghedira, Hela Radhouane, Khaled Mezni, Essia Yahiaoui, Safia Stambouli, Hela Yedeas, Mohamed Dehmani Belaid, Asma Ammar, Chiraz Kacem, Karima Zriba, Samy Msadek, Fehmi Yedeas, Mondher Harbaoui, Ahmed Chkili, Ridha |
author_sort | Ghedira, Hela |
collection | PubMed |
description | BACKGROUND: Various hematological malignancies, including multiple myeloma, plasmacytoma, aggressive lymphoma, and indolent lymphoma, rarely result in spinal cord compression. METHODS: Here, we retrospectively analyzed 32 patients with multiple myeloma (50%), plasmacytoma (13%), aggressive lymphoma (28%), and indolent lymphoma (9%), resulting in spinal cord compression (2004 and 2016). Patients averaged 57 years of age and presented with the indolent onset of spinal cord compression (91% of cases) resulting mostly in motor deficits (69%). RESULTS: Local treatment modalities included radiotherapy (RT) (28%) alone, decompressive surgery (28%) alone, or decompressive surgery with consolidation RT (40%). The 1-year overall survival was 70%, and the progression-free survival frequency was 62%. CONCLUSION: This study highlighted the importance of standardizing the indications for RT alone versus RT with surgery depending on the patient’s underlying pathological diagnosis, neurological deficits, and radiological findings. |
format | Online Article Text |
id | pubmed-7656002 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Scientific Scholar |
record_format | MEDLINE/PubMed |
spelling | pubmed-76560022020-11-13 Impact of local treatment on survival from hematological malignancies causing spinal cord compression Ghedira, Hela Radhouane, Khaled Mezni, Essia Yahiaoui, Safia Stambouli, Hela Yedeas, Mohamed Dehmani Belaid, Asma Ammar, Chiraz Kacem, Karima Zriba, Samy Msadek, Fehmi Yedeas, Mondher Harbaoui, Ahmed Chkili, Ridha Surg Neurol Int Original Article BACKGROUND: Various hematological malignancies, including multiple myeloma, plasmacytoma, aggressive lymphoma, and indolent lymphoma, rarely result in spinal cord compression. METHODS: Here, we retrospectively analyzed 32 patients with multiple myeloma (50%), plasmacytoma (13%), aggressive lymphoma (28%), and indolent lymphoma (9%), resulting in spinal cord compression (2004 and 2016). Patients averaged 57 years of age and presented with the indolent onset of spinal cord compression (91% of cases) resulting mostly in motor deficits (69%). RESULTS: Local treatment modalities included radiotherapy (RT) (28%) alone, decompressive surgery (28%) alone, or decompressive surgery with consolidation RT (40%). The 1-year overall survival was 70%, and the progression-free survival frequency was 62%. CONCLUSION: This study highlighted the importance of standardizing the indications for RT alone versus RT with surgery depending on the patient’s underlying pathological diagnosis, neurological deficits, and radiological findings. Scientific Scholar 2020-10-21 /pmc/articles/PMC7656002/ /pubmed/33194285 http://dx.doi.org/10.25259/SNI_592_2020 Text en Copyright: © 2020 Surgical Neurology International http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Ghedira, Hela Radhouane, Khaled Mezni, Essia Yahiaoui, Safia Stambouli, Hela Yedeas, Mohamed Dehmani Belaid, Asma Ammar, Chiraz Kacem, Karima Zriba, Samy Msadek, Fehmi Yedeas, Mondher Harbaoui, Ahmed Chkili, Ridha Impact of local treatment on survival from hematological malignancies causing spinal cord compression |
title | Impact of local treatment on survival from hematological malignancies causing spinal cord compression |
title_full | Impact of local treatment on survival from hematological malignancies causing spinal cord compression |
title_fullStr | Impact of local treatment on survival from hematological malignancies causing spinal cord compression |
title_full_unstemmed | Impact of local treatment on survival from hematological malignancies causing spinal cord compression |
title_short | Impact of local treatment on survival from hematological malignancies causing spinal cord compression |
title_sort | impact of local treatment on survival from hematological malignancies causing spinal cord compression |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656002/ https://www.ncbi.nlm.nih.gov/pubmed/33194285 http://dx.doi.org/10.25259/SNI_592_2020 |
work_keys_str_mv | AT ghedirahela impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression AT radhouanekhaled impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression AT mezniessia impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression AT yahiaouisafia impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression AT stamboulihela impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression AT yedeasmohameddehmani impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression AT belaidasma impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression AT ammarchiraz impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression AT kacemkarima impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression AT zribasamy impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression AT msadekfehmi impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression AT yedeasmondher impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression AT harbaouiahmed impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression AT chkiliridha impactoflocaltreatmentonsurvivalfromhematologicalmalignanciescausingspinalcordcompression |